{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/TYRA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T04:46:56.764Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4754,"canonical_name":"Tyra Biosciences, Inc.","cik":"0001863127","uei":null,"lei":null,"duns":null,"ticker":"TYRA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":22},"count":22,"timeline":[{"ts":"2026-09-21","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Tyra Biosciences, Inc. — 2026-09-21","url_slug":"/sec/cik-0001863127/schedule-13g/0000921895-26-002613","accession_number":"0000921895-26-002613","importance":55},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Tyra Biosciences, Inc. — 2026-09-17","url_slug":"/sec/cik-0001863127/4/0001193125-26-394734","accession_number":"0001193125-26-394734","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Tyra Biosciences, Inc. — 2026-09-15","url_slug":"/sec/cik-0001863127/8-k/0001193125-26-390951","accession_number":"0001193125-26-390951","importance":35},{"ts":"2026-09-15","kind":"sec.filing","form_type":"424B5","title":"424B5 — Tyra Biosciences, Inc. — 2026-09-15","url_slug":"/sec/cik-0001863127/424b5/0001193125-26-390947","accession_number":"0001193125-26-390947","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"FWP","title":"FWP — Tyra Biosciences, Inc. — 2026-09-14","url_slug":"/sec/cik-0001863127/fwp/0001193125-26-389801","accession_number":"0001193125-26-389801","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"S-3ASR","title":"S-3ASR — Tyra Biosciences, Inc. — 2026-09-14","url_slug":"/sec/cik-0001863127/s-3asr/0001193125-26-389752","accession_number":"0001193125-26-389752","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — Tyra Biosciences, Inc. — 2026-09-11","url_slug":"/sec/cik-0001863127/4/0001193125-26-389333","accession_number":"0001193125-26-389333","importance":30},{"ts":"2026-09-09","kind":"sec.insider.p","reporter":"Verjee Rehan","title":null,"shares":971.8943,"price_per_share":20.5784,"usd_value":20000,"security_title":"Common Stock","importance":50.02000002966312},{"ts":"2026-09-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Tyra Biosciences, Inc. — 2026-09-09","url_slug":"/sec/cik-0001863127/8-k/0001193125-26-385886","accession_number":"0001193125-26-385886","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Tyra Biosciences, Inc. — 2026-08-14","url_slug":"/sec/cik-0001863127/schedule-13g-a/0000908834-26-000427","accession_number":"0000908834-26-000427","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Tyra Biosciences, Inc. — 2026-08-04","url_slug":"/sec/cik-0001863127/10-q/0001193125-26-332995","accession_number":"0001193125-26-332995","importance":45},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Tyra Biosciences, Inc. — 2026-08-04","url_slug":"/sec/cik-0001863127/8-k/0001193125-26-332752","accession_number":"0001193125-26-332752","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"424B5","title":"424B5 — Tyra Biosciences, Inc. — 2026-08-04","url_slug":"/sec/cik-0001863127/424b5/0001193125-26-333055","accession_number":"0001193125-26-333055","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Tyra Biosciences, Inc. — 2026-07-30","url_slug":"/sec/cik-0001863127/schedule-13g/0002012383-26-003114","accession_number":"0002012383-26-003114","importance":55},{"ts":"2026-06-26","kind":"sec.form144","reporter":"NEXTECH VI ONCOLOGY SCSP","title":"Shareholder","shares":308379,"usd_value":9541246,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001628280-26-045813","importance":41.908249252},{"ts":"2026-06-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Tyra Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001863127/8-k/0001193125-26-253435","accession_number":"0001193125-26-253435","importance":35},{"ts":"2026-06-01","kind":"sec.form144","reporter":"NEXTECH VI ONCOLOGY SCSP","title":"Shareholder","shares":300000,"usd_value":10023000,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001628280-26-039506","importance":42.004599999999996},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Tyra Biosciences, Inc. — 2026-05-13","url_slug":"/sec/cik-0001863127/10-q/0001193125-26-220645","accession_number":"0001193125-26-220645","importance":45},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Tyra Biosciences, Inc. — 2026-05-13","url_slug":"/sec/cik-0001863127/8-k/0001193125-26-220638","accession_number":"0001193125-26-220638","importance":35},{"ts":"2026-05-12","kind":"sec.13dg","reporter":"Farallon Capital Partners, L.P.","shares":3580818,"percent_of_class":6.6,"security_title":"SCHEDULE 13G/A","accession_number":"0000908834-26-000228","excerpt":null,"importance":55},{"ts":"2026-05-12","kind":"sec.form144","reporter":"Daniel Bensen","title":"Officer","shares":8000,"usd_value":274000,"security_title":"Common","approx_sale_date":"2026-05-12","accession_number":"0001628280-26-034243","importance":40.0548},{"ts":"2026-05-12","kind":"sec.filing","form_type":"144","title":"144 — Tyra Biosciences, Inc. — 2026-05-12","url_slug":"/sec/cik-0001863127/144/0001628280-26-034243","accession_number":"0001628280-26-034243","importance":30}]}